| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 680430 | 74060 | GABAPENTINA SANDOZ 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | GABAPENTINA SANDOZ 800 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 90 comprimidos | 800 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74060/74060_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74060/74060_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-11-03 | 1 | 1 | 1 | 2011-11-03 | 2011-11-03 | 0 | 2013-01-29 | View Edit Delete | ||||||||||||
| 680698 | 74080 | TRAMADOL/PARACETAMOL SANDOZ 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TRAMADOL/PARACETAMOL SANDOZ 37,5 mg/325 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 37,5 mg/325 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74080/74080_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74080/74080_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-10-18 | 1 | 1 | 1 | 2012-07-15 | 2012-07-15 | 1 | 2012-08-27 | View Edit Delete | ||||||||||||
| 681024 | 74189 | TAMSULOSINA SANDOZ 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | TAMSULOSINA SANDOZ 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 0,4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74189/74189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74189/74189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-06-07 | 1 | 1 | 1 | 2013-05-12 | 2013-05-12 | 0 | 2011-11-23 | View Edit Delete | ||||||||||||
| 681267 | 74247 | IRBESARTAN/HIDROCLOROTIAZIDA SANDOZ 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA SANDOZ 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 300 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74247/74247_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74247/74247_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2011-11-29 | View Edit Delete | ||||||||||||
| 677257 | 73192 | LOSARTAN/HIDROCLOROTIAZIDA ALMUS 50 mg/12.5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN/HIDROCLOROTIAZIDA ALMUS 50 mg/12.5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 50 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73192/73192_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73192/73192_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2010-12-15 | 1 | 1 | 1 | 2010-12-15 | 2010-12-15 | 1 | 2011-07-03 | View Edit Delete | ||||||||||||
| 677258 | 73193 | LOSARTAN/HIDROCLOROTIAZIDA ALMUS 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN/HIDROCLOROTIAZIDA ALMUS 100 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 100 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73193/73193_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73193/73193_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2010-12-15 | 1 | 1 | 1 | 2010-12-15 | 2010-12-15 | 1 | 2011-07-03 | View Edit Delete | ||||||||||||
| 677557 | 73524 | GABAPENTINA ALMUS 400 mg CAPSULAS DURAS EFG | GABAPENTINA ALMUS 400 mg CAPSULAS DURAS EFG , 90 cápsulas | 400 mg | 5 | 90 | 43 | 90 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73524/73524_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73524/73524_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 677558 | 73521 | GABAPENTINA ALMUS 300 mg CAPSULAS DURAS EFG | GABAPENTINA ALMUS 300 mg CAPSULAS DURAS EFG , 90 cápsulas | 300 mg | 5 | 90 | 43 | 90 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73521/73521_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73521/73521_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2011-02-15 | 1 | 1 | 1 | 2011-02-15 | 2011-02-15 | 1 | 2011-07-04 | View Edit Delete | ||||||||||||
| 680763 | 74098 | MONTELUKAST ALMUS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | MONTELUKAST ALMUS 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74098/74098_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74098/74098_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 37937 | ALMUS FARMACEUTICA S.A.U. | 2011-05-23 | 1 | 1 | 1 | 2013-01-18 | 2013-01-18 | 1 | 2013-02-25 | View Edit Delete | ||||||||||||
| 678883 | 73308 | MEDIKINET 5 mg CAPSULAS DURAS DE LIBERACION MODIFICADA | MEDIKINET 5 mg CAPSULAS DURAS DE LIBERACION MODIFICADA , 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73308/73308_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73308/73308_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5541 | MEDICE IBERICA S.L. | 2011-06-07 | 1 | 1 | 1 | 2011-06-07 | 2011-06-07 | 1 | 2011-11-11 | Lista II | View Edit Delete | |||||||||||
| 681199 | 74227 | TAMSULOSINA QUALIGEN 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG | TAMSULOSINA QUALIGEN 0,4 mg COMPRIMIDOS DE LIBERACION PROLONGADA EFG , 30 comprimidos | 0,4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74227/74227_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74227/74227_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2011-06-13 | 1 | 1 | 1 | 2013-05-24 | 2013-05-24 | 0 | 2013-06-21 | View Edit Delete | ||||||||||||
| 680645 | 61006 | PROGRAF 1 mg CAPSULAS DURAS | PROGRAF 1 mg CAPSULAS DURAS , 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61006/61006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61006/61006_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 40569 | ASTELLAS PHARMA S.A. | 1996-07-01 | 1 | 1 | 1 | 1996-07-01 | 1996-07-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 680660 | 61005 | PROGRAF 5 mg CAPSULAS DURAS | PROGRAF 5 mg CAPSULAS DURAS , 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61005/61005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61005/61005_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 40569 | ASTELLAS PHARMA S.A. | 1996-07-01 | 1 | 1 | 1 | 1996-07-01 | 1996-07-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 677112 | 61230 | PRODERMA 50 mg CAPSULAS DURAS | PRODERMA 50 mg CAPSULAS DURAS, 30 cápsulas | 50 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61230/61230_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61230/61230_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 1999-12-23 | 1 | 1 | 1 | 1999-12-23 | 1999-12-23 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 679953 | 73972 | ALOCARE 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ALOCARE 1 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73972/73972_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73972/73972_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39651 | INDUSTRIAL FARMACEUTICA CANTABRIA S.A. | 2011-04-29 | 1 | 1 | 1 | 2022-05-19 | 2022-05-19 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 678588 | 73434 | CAPENON HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73434/73434_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73434/73434_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 678643 | 73450 | SEVIKAR HCT 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR HCT 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73450/73450_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73450/73450_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2011-02-23 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 678647 | 73451 | SEVIKAR HCT 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR HCT 40 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 40 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73451/73451_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73451/73451_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2011-02-23 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 678657 | 73453 | SEVIKAR HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEVIKAR HCT 40 mg/5 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 40 mg/5 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73453/73453_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73453/73453_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-23 | 1 | 1 | 1 | 2011-02-23 | 2011-02-23 | 1 | 2011-05-26 | View Edit Delete | ||||||||||||
| 679042 | 73433 | CAPENON HCT 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CAPENON HCT 20 mg/5 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 20 mg/5 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73433/73433_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73433/73433_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 39736 | DAIICHI SANKYO ESPANA S.A. | 2011-02-22 | 1 | 1 | 1 | 2011-02-22 | 2011-02-22 | 1 | 2011-10-28 | View Edit Delete |
Page 285 of 1036, showing 20 records out of 20704 total, starting on record 5681, ending on 5700